OBSIDIAN Trademark

Trademark Overview

On Thursday, May 18, 2017, a trademark application was filed for OBSIDIAN with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN trademark a serial number of 87455621. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 30, 2024. This trademark is owned by OBSIDIAN THERAPEUTICS, INC.. The OBSIDIAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of gene therapy
obsidian

General Information

Serial Number87455621
Word MarkOBSIDIAN
Filing DateThursday, May 18, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 30, 2024
Registration Number5409037
Registration DateTuesday, February 20, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Description of MarkThe mark consists of the word "OBSIDIAN" where the letter "O" is incomplete and partially surrounds a short vertical line.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development in the field of gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 30, 2024
Primary Code042
First Use Anywhere DateSaturday, December 16, 2017
First Use In Commerce DateSaturday, December 16, 2017

Trademark Owner History

Party NameOBSIDIAN THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameOBSIDIAN THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameOBSIDIAN THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Wednesday, May 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 25, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 15, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2018TEAS STATEMENT OF USE RECEIVED
Monday, May 22, 2017NEW APPLICATION ENTERED
Tuesday, August 15, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 17, 2017ASSIGNED TO EXAMINER
Friday, August 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2018USE AMENDMENT FILED
Tuesday, January 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 16, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 18, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 17, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 30, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

obsidian gene therapy field development research pharmaceutical